DAFTAR PUSTAKA

Baraldi O, Valentini C, Donati G, Comai G, Cuna V, Capelli I, et al., 2015.

Hepatorenal Syndrome: Update On Diagnosis And Treatment, World
Journal of W J N Nephrology, pp: 511-520
Erly B, Carey WD, Kapoor B, McKinney M, Tam M, Wang W, 2015.
Hepatorenal Syndrome: A Review of Pathophysiology and Current
Treatment Options, Seminars In Interventional Radiology Vol 32 No. 4,
pp: 445-455
Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V, 2007. Diagnosis, prevention
and treatment of hepatorenal syndrome in cirrhosis. Gut. Sep;56(9):1310-
1318.
Effendi I, Ali Z, 2014. Sindrom Hepatorenal, In: Buku Ajar Ilmu Penyakit Dalam
Edisi VI, pp: 2176- 2183.
Ng CKF, Chan MHM, Tai MHL, Lam CWK, 2007, Hepatorenal Syndrome.
Chan S, Au K, Francis R, Mudge DW, Johnson DW, Rahman T, 2017. An Update
on Hepatorenal Syndrome, Journal of Renal and Hepatic Disorders, pp:
55-61
Lei L, Li L, Zhang h, 2017. Advances in the Diagnosis and Treatment of Acute
Kidney Injury in Cirrhosis Patients, BioMed Research International, pp: 1-
7.
Bucsics T, Krones E, 2017. Renal Dysfunstion in Cirrhosis: Acute Kidney Injury
and The Hepatorenal Syndrome, Gastroenterology Report, pp: 127-137
Mattos AZ, Mattos AA, Sanchez NM, 2016. Hepatorenal Syndrome: Current
Concept Related To Diagnosis and Management, Annals of Hepatology,
pp: 474-481
Cheney CP, GoldbergbEM, Chopra S, 2004. Cirrhosis and Portal Hypertension:
An Overview, In: Handbook Of Liver Disease Second Edition Chapter 9,
pp: 125-138.
Ginès P, Guevara M, Arroyo V, Rodés J, 2003. Hepatorenal Syndrome, Lancet,
pp: 1819–27
Lenz K, Buder R, Kaspun L, Voglmayr M, 2015. Treatment and Management of
Ascites and Hepatorenal Syndrome; An Update, Theraupetic Advances in
Gastroenterology, pp: 83-100.
Wadei HM, Mai ML, Ahsan N, Gonwa T, 2006. Hepatorenal Syndrome:
Pathophysiology and Management, Clnical Journal American Society of
Nephrology, pp: 1066-1079
Low G, Alexander GJM, Lomas DJ, 2015. Hepatorenal Syndrome: Aetiology,
Diagnosis, and Treatment, Gastroenterology Research and Practice, pp: 1-
11.
Suva M, 2014. A Brief Review on Liver Cirrhosis: Epidemiology, Etiology,
Pathophysiology, Symptoms, Diagnosis and Its Management, Inventi
Rapid: Molecular Pharmacology Vol. 2014
Kalil JR, Cerqueira LA, Barbosa DS, Motta MP, Nery MS, Bittencourt PL, 2009.
Poor Outcomes With Treatment Hepatorenal Syndrome, Type 1 With
Splancnic Vasokonstriktor And Albumin. Arq Gastroenterol 46 pp: 214-
218.